IRIS
SIVORI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.293
Totale 12.293
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.293
Totale 12.293
Salva come PNG Salva come JPEG
Città #
Genova 8.950
Rapallo 1.172
Vado Ligure 1.074
Genoa 1.051
Bordighera 46
Totale 12.293
Salva come PNG Salva come JPEG
Nome #
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 168
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 164
NK/DC crosstalk in anti-viral response. 161
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 157
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 152
Markers and function of human NK cells in normal and pathological conditions 149
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 146
NK cells and their receptors during viral infections. 144
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 143
2B4 functions as a co-receptor in human NK cell activation 143
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 143
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing 142
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 142
Bridging innate NK cell Functions with Adaptive Immunity. 141
Stimulatory receptors in NK and T cells. 140
Features of Memory-Like and PD-1+ Human NK Cell Subsets 138
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 135
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 133
Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products 131
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 131
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells 130
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 129
Function and specificity of human natural killer cell receptors. 129
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. 128
A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. 127
Human NK receptors: from the molecules to the therapy of high risk leukemias. 127
Pathogen-induced private conversations between natural killer and dendritic cells 126
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 125
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. 123
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 123
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 122
Harnessing NK Cells for Cancer Treatment 122
Natural killer lymphocytes: "null cells" no more. 121
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 119
Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients 119
Report from the Eleventh Killer Immunoglobulin-like Receptor (KIR) Workshop: novel insights on KIR polymorphism, ligand recognition, expression and function 119
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 118
CD56 is a pathogen recognition receptor on human natural killer cells 118
Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. 117
Human NK cell response to pathogens 117
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 116
p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. 114
Identification of a new surface molecule involved in the mechanism of cell to cell adhesion between human NK and tumor target cells. 114
Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity 114
Natural killer cell-triggering receptors in patients with acute leukaemia. 113
TLR/NCR/KIR: Which One to Use and When? 113
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 113
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 111
Natural killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT 111
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 110
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia 109
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 109
Human NK Cells and Herpesviruses: Mechanisms of Recognition, Response and Adaptation 109
Identification and molecular characterization of a natural mutant of the p50.2/KIR2DS2 activating NK receptor that fails to mediate NK cell triggering. 108
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. 108
NK cells: innate immunity against hematological malignancies? 108
Natural Killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT. 107
Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. 106
NK Receptors: Tools for a Polyvalent Cell Family 106
Expression and Function of the Natural Cytotoxicity Receptor NKp46 on Circulating Malignant CD4(+) T Lymphocytes of Sézary Syndrome Patients. 105
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 105
Human natural killer cell receptors and co-receptors. 105
General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect. 105
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 105
Cutaneous T Cell Lymphoma Cells Express a Novel Allelic Form of the p140/Killer Cell Immunoglobulin-Like Receptor 104
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 104
Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursors. 103
p46, a novel natural killer cell-specific surface molecule that mediates cell activation. 102
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 100
Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. 99
Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. 97
In Celiac Disease, a Subset of Autoantibodies against Transglutaminase Binds Toll-like Receptor 4 and Induces Activation of Monocytes. 96
IFN-alpha-mediated increase in cytolytic activity of maturing NK cell upon exposure to HSV-infected myelomonocytes. 95
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications 94
NK Cell-Based Immunotherapy for Hematological Malignancies 94
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. 93
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 92
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. 91
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 90
Dysregulation of regulatory CD56 (bright) NK cells/T cells interactions in multiple sclerosis 89
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans 88
The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. 87
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts. 87
CD19 Redirected CAR NK Cells Are Equally Effective but Less Toxic Than CAR T Cells 87
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 87
ANALYSIS OF THE INTERACTION OF MATURING NK CELLS WITHREPLICATING VIRUSES: STRONG UPREGULATION OF NCREXPRESSION AND OF CYTOTOXICITY BY HSV-1, NOT BY HIV-1 85
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 84
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 84
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. 83
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 82
The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase. 81
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2 81
Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content 79
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 78
High performance liquid chromatographic strategy for the analysis of exopolysaccharides extracted from pathogenic bacteria. 75
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 75
Il recettore NK per gli alleli HLA-Bw4 72
Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. 72
Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules. 71
NK-DC intercourse during inflammation 71
Totale 11.138
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.164
article - articoli 33.667
book - libri 662
conference - conferenze 3.095
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 740
Totale 76.328
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.087 0 0 0 0 0 0 481 243 330 571 349 113
2020/20211.091 76 84 95 65 46 164 75 68 107 135 85 91
2021/20221.471 57 107 130 149 53 91 80 331 72 152 67 182
2022/20231.445 156 109 17 148 224 247 2 122 257 10 129 24
2023/2024773 48 94 17 93 71 76 36 78 56 46 47 111
2024/20251.143 62 180 136 150 357 253 5 0 0 0 0 0
Totale 12.565